1,721,047 research outputs found
Utilizzo di una preparazione intravitreale di triamcinolone acetonide senza conservanti nella chirurgia vitreo-retinica.
Choroidal thickness changes after intravitreal anti-VEGF therapy for age-related macular degeneration: ranibizumab versus aflibercept
In this retrospective study, the medical records of 28 patients with nAMD treated with at least 3 consecutive monthly injections of ranibizumab (0.5 mg/0.05 mL) or aflibercept (2mg /0.05 mL) between December 2013 and June 2014 and who were followed up for at least 3 months were reviewed. Subfoveal choroidal thickness was measured using enhanced-depth-imaging optical coherence tomograph
Trattamento laser ICG-guidato delle neovascolarizzazioni in corso di degenerazione maculare.
Fattori di rischio protrombotici nei pazienti con neuropatia ottica ischemica anteriore non arteritica.
Indocyanine green angiographic findings in systemic lupus erythematosus choroidopathy
PURPOSE: To report two patients affected with systemic lupus erythematosus choroidopathy studied with combined fluorescein angiography and indocyanine green angiography. In particular, the presence of choroidal abnormalities at indocyanine green angiography, which could not be detected by fluorescein angiography, was studied. DESIGN: Observational case reports. METHODS: Retrospective review of the clinical and photographic records of two patients with systemic lupus erythematosus in whom choroidopathy developed. RESULTS: Four findings were unveiled by indocyanine green angiography: focal, transient hypofluorescent areas in the very early phase; fuzziness of large choroidal vessels with late diffuse zonal choroidal hyperfluorescence; poorly,defined areas of choroidal hypofluorescence visible up to the late phase; and focal cluster of pinpoint spots of choroidal hyperfluorescence visible from the intermediate to late phase. CONCLUSION: Indocyanine green angiography can prod vide information that is not detectable by clinical or fluorescein angiographic examination in patients with systemic lupus erythematosus choroidopathy. This information may prove useful in better understanding the pathogenesis of systemic lupus erythematosus choroidopathy. (C) 2002 by Elsevier Science Inc. All rights reserved
- …
